Sana Biotechnology, Inc.SANANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +19.76% | +9.34% | +1.69% | +10.65% | +7.17% |
| Weighted Average Shares Diluted Growth | +19.76% | +9.34% | +1.69% | +10.65% | +7.17% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -11.37% | -34.62% | -41.54% | -22.16% | -16.79% |
| Book Value per Share Growth | -27.24% | -49.03% | -64.52% | -39.65% | -40.07% |
| Debt Growth | -9.51% | -13.93% | -13.26% | -6.61% | -16.28% |
| R&D Expense Growth | -51.90% | -58.56% | +21.54% | -30.35% | -41.70% |
| SG&A Expenses Growth | -16.87% | -29.41% | -37.11% | -26.81% | -29.47% |